A Flexible-Dose Titration Study of Aptensio XR in Children Ages 4 to Under 6 Years Diagnosed With ADHD

NCT02683265 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

158

Enrollment

INDUSTRY

Sponsor class

Conditions

Attention Deficit Disorder With Hyperactivity

Interventions

DRUG: Aptensio XR
DRUG: Placebo

Sponsor

Rhodes Pharmaceuticals, L.P.